chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Pyrexia
Clinical narrative: Per mom stated that after the covid Pfizer injection he a fever missed dose on Tuesday.; Per mom stated that after the covid Pfizer injection he a fever missed dose on Tuesday.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent. Other Case identifier(s): 20210906000327.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRODUCT DOSE OMISSION ISSUE (non-serious), PYREXIA (non-serious), outcome "unknown" and all described as "Per mom stated that after the covid Pfizer injection he a fever missed dose on Tuesday".  Additional information: Per mom stated that after the Covid Pfizer injection he a fever missed dose on Tuesday.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: stated that she is still experiencing tachycardia up until now; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program . The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 30Apr2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TACHYCARDIA (non-serious) with onset 30Apr2021, outcome "not recovered", described as "stated that she is still experiencing tachycardia up until now".  Additional information: NDC number of unknown drug was Not Provided. The reason for no lot number of drug was complainant hung up abruptly/transfer incomplete.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Lip swelling, Nasal oedema, Swelling face
Clinical narrative: my eyes, face/were swollen; my eyes, face/were swollen; my eyes, face, nose, and top lip were swollen; top lip were swollen; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 19Aug2021 19:30 (Lot number: FC3181) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "known allergies: penicillin" (unspecified if ongoing), notes: known allergies: Salmon, penicillin, neutrogena facial moisturizer, Burt's Bees lip balm, Lacombemakeup; "known allergies: Salmon" (unspecified if ongoing), notes: known allergies: Salmon, penicillin, neutrogena facial moisturizer, Burt's Bees lip balm, Lacombemakeup; "known allergies: neutrogena facial moisturizer" (unspecified if ongoing), notes: known allergies: Salmon, penicillin, neutrogena facial moisturizer, Burt's Bees lip balm, Lacombemakeup; "known allergies: Burt's Bees lip balm" (unspecified if ongoing), notes: known allergies: Salmon, penicillin, neutrogena facial moisturizer, Burt's Bees lip balm, Lacombemakeup; "known allergies: Lacombemakeup" (unspecified if ongoing), notes: known allergies: Salmon, penicillin, neutrogena facial moisturizer, Burt's Bees lip balm, Lacombemakeup. Concomitant medication(s) included: BIOTIN; ZINC. The following information was reported: EYE SWELLING (non-serious), SWELLING FACE (non-serious) all with onset 20Aug2021 06:45, outcome "not recovered" and all described as "my eyes, face/were swollen"; NASAL OEDEMA (non-serious) with onset 20Aug2021 06:45, outcome "not recovered", described as "my eyes, face, nose, and top lip were swollen"; LIP SWELLING (non-serious) with onset 20Aug2021 06:45, outcome "not recovered", described as "top lip were swollen". Therapeutic measures were not taken as a result of eye swelling, swelling face, nasal oedema, lip swelling.  Additional information: No other vaccine in four weeks. No covid prior vaccination. Covid tested post vaccination: No. Patient received the vaccine between 730 and 800 pm that night. The next morning her eyes, face, nose, and top lip were swollen. Her face was still swollen, but just not as bad. Facility type vaccine: Pharmacy or Drug Store.  Follow-up attempts are completed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: shortness of breath; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 43 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 15Sep2021 16:00 (Lot number: FC3183) at the age of 43 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DYSPNOEA (non-serious) with onset 15Sep2021 18:00, outcome "not recovered", described as "shortness of breath".  Additional Information: No other vaccinations within four weeks prior to the first administration date.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Occupational exposure to product, Ocular hyperaemia, Product use issue
Clinical narrative: There was a splatter and she thought she may have gotten some product into her eye; Eye was red, after vaccine exposure in eye.; Occupational exposure: another Pharmacist was diluting the Covid vaccine vial and the syringe broke, and the Pharmacist got vaccine in her eye.; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team for a Pfizer sponsored program.  A 30 year-old female patient (pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRODUCT USE ISSUE (non-serious) with onset 16Sep2021, outcome "unknown", described as "There was a splatter and she thought she may have gotten some product into her eye"; OCULAR HYPERAEMIA (non-serious) with onset 16Sep2021, outcome "unknown", described as "Eye was red, after vaccine exposure in eye."; OCCUPATIONAL EXPOSURE TO PRODUCT (non-serious) with onset 16Sep2021, outcome "unknown", described as "Occupational exposure: another Pharmacist was diluting the Covid vaccine vial and the syringe broke, and the Pharmacist got vaccine in her eye.".  Additional information: The Pharmacist while diluting vaccine was unsure what had happened or if the vaccine did splash into her eye.  She was having issues with the syringe and the pressure built up in the vial and the syringe busted, but not the vial. There was a splatter and she thought she may have gotten some product into her eye.  She immediately flushed her eye. She did speak to her OB and was advised that they did not see this as an emergency situation and further advised her to follow up if she experienced continued irritation.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Pain
Clinical narrative: Chest pain; Shortness of breath; 'shooting' at my left arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 21Aug2021 (Lot number: FD7204) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose: 24Jul2021, Batch/lot number: FD7206), administration date: 24Jul2021, for Covid-19 Immunization. The following information was reported: CHEST PAIN (non-serious), outcome "unknown", described as "Chest pain"; DYSPNOEA (non-serious), outcome "unknown", described as "Shortness of breath"; PAIN (non-serious), outcome "unknown", described as "'shooting' at my left arm".  Additional information: Patient had 2nd Pfizer shot on 21Aug and since then this was the 3rd time today, patient been getting like chest pain, shortness of breath and 'shooting' at left arm and was just wondering, patient tried to call family doctor but they are closed at the moment and wasn't just sure if needed to go to a hospital or what the next step should be.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Headache, Influenza, Pain, Rash
Clinical narrative: having really bad body aches; bad headaches; Also rash like bruising on both lower legs; Also rash like bruising on both lower legs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 07Sep2021 16:45 (Lot number: 301308A) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma and High Blood Pressure" (unspecified if ongoing); "Asthma and High Blood Pressure" (unspecified if ongoing). The patient took concomitant medications.  The following information was reported: PAIN (non-serious) with onset 15Sep2021 17:30, outcome "not recovered", described as "having really bad body aches"; HEADACHE (non-serious) with onset 15Sep2021 17:30, outcome "not recovered", described as "bad headaches"; RASH (non-serious), CONTUSION (non-serious) all with onset 15Sep2021 17:30, outcome "not recovered" and all described as "Also rash like bruising on both lower legs". The events "having really bad body aches", "bad headaches", "also rash like bruising on both lower legs" and "also rash like bruising on both lower legs" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain, headache, rash, contusion.  Clinical course: Patient day 8 started having really bad body aches and bad headaches. Also rash like bruising on both lower legs. Went to emergency on day 9 they did COVID, flu and strep test all came back negative. Still having all same symptoms. No COVID prior vaccination.COVID tested post vaccination. No known allergies. No other vaccine in four weeks. Patient took other medications in two weeks. No COVID prior vaccination.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Streptococcus test
Clinical narrative: having really bad body aches; bad headaches; Also rash like bruising on both lower legs; Also rash like bruising on both lower legs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 07Sep2021 16:45 (Lot number: 301308A) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma and High Blood Pressure" (unspecified if ongoing); "Asthma and High Blood Pressure" (unspecified if ongoing). The patient took concomitant medications.  The following information was reported: PAIN (non-serious) with onset 15Sep2021 17:30, outcome "not recovered", described as "having really bad body aches"; HEADACHE (non-serious) with onset 15Sep2021 17:30, outcome "not recovered", described as "bad headaches"; RASH (non-serious), CONTUSION (non-serious) all with onset 15Sep2021 17:30, outcome "not recovered" and all described as "Also rash like bruising on both lower legs". The events "having really bad body aches", "bad headaches", "also rash like bruising on both lower legs" and "also rash like bruising on both lower legs" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain, headache, rash, contusion.  Clinical course: Patient day 8 started having really bad body aches and bad headaches. Also rash like bruising on both lower legs. Went to emergency on day 9 they did COVID, flu and strep test all came back negative. Still having all same symptoms. No COVID prior vaccination.COVID tested post vaccination. No known allergies. No other vaccine in four weeks. Patient took other medications in two weeks. No COVID prior vaccination.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Furuncle, Pruritus, Rash macular
Clinical narrative: Patient complained of bruising/purple blotching from the waist down.; Patient complained of bruising/purple blotching from the waist down.; she also complained of itching and the formation of boils from the waist down.; she also complained of itching and the formation of boils from the waist down.; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 73 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 27Aug2021 18:45 (Lot number: FC3182) at the age of 73 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Arthritis" (unspecified if ongoing), notes: other medical history: Arthritis; "Hyperlipidemia" (unspecified if ongoing), notes: other medical history: Hyperlipidemia; "known allergies:Sulfa" (unspecified if ongoing), notes: known allergies:Sulfa. The patient's concomitant medications were not reported. Past drug history included: Cipro, reaction(s): "known allergies", notes: known allergies:Cipro; Keflex, reaction(s): "known allergies", notes: known allergies: Keflex; Codeine, reaction(s): "known allergies", notes: known allergies: Codeine.  The following information was reported: CONTUSION (non-serious), RASH MACULAR (non-serious) all with onset 28Aug2021, outcome "not recovered" and all described as "Patient complained of bruising/purple blotching from the waist down."; PRURITUS (non-serious), FURUNCLE (non-serious) all with onset 28Aug2021, outcome "not recovered" and all described as "she also complained of itching and the formation of boils from the waist down.". The events "patient complained of bruising/purple blotching from the waist down.", "patient complained of bruising/purple blotching from the waist down.", "she also complained of itching and the formation of boils from the waist down." and "she also complained of itching and the formation of boils from the waist down." were evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of contusion, rash macular, pruritus, furuncle.  Additional information: The patient was not hospitalized or hospitalization was not prolonged. It was unknown that patient was diagnosed with COVID-19 prior to vaccination. It was unknown that patient has been tested for COVID-19, since the vaccination. the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine.  Follow-up attempts are completed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory disorder
Clinical narrative: had a little bit of issues with the first one, but she already had respiratory issues before; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from agent. The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 08Aug2021 (Lot number: FC3181, Expiration Date: 28Feb2022) at the age of 46 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: H1n1 vaccine (In past about 10 years with the H1N1 vaccine she ended up in the ICU and with neuropathy and myopathy.), for Influenza immunisation, reaction(s): "myopathy", "neuropathy". The following information was reported: RESPIRATORY DISORDER (non-serious) with onset Aug2021, outcome "unknown", described as "had a little bit of issues with the first one, but she already had respiratory issues before".  Additional information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was taking medications prior to the event being reported (details not reported). Patient received no other vaccines on the same day. No investigation assessment. Vaccine was not administered at facility.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Dysstasia, Fatigue, Pain
Clinical narrative: extreme vertigo; Could not stand up or sit up for most of that day and Tuesday the 7th of September.; chills; body aches; fever; some fatigue; feeling a bit out of balance; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Sep2021 12:00 (Lot number: FD8448) at the age of 53 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19? Yes. There were no concomitant medications. The following information was reported: CHILLS (non-serious) with onset 01Sep2021 21:00, outcome "not recovered", described as "chills"; PAIN (non-serious) with onset 01Sep2021 21:00, outcome "not recovered", described as "body aches"; PYREXIA (non-serious) with onset 01Sep2021 21:00, outcome "not recovered", described as "fever"; FATIGUE (non-serious) with onset 01Sep2021 21:00, outcome "not recovered", described as "some fatigue"; VERTIGO (non-serious) with onset 06Sep2021, outcome "recovered" (Sep2021), described as "extreme vertigo"; DYSSTASIA (non-serious) with onset 06Sep2021, outcome "not recovered", described as "Could not stand up or sit up for most of that day and Tuesday the 7th of September."; BALANCE DISORDER (non-serious) with onset Sep2021, outcome "not recovered", described as "feeling a bit out of balance". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chills, pain, pyrexia, fatigue, vertigo, dysstasia, balance disorder.  Additional Information: It was reported that the patient had no known allergies. Facility where the most recent COVID-19 vaccine was administered at workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19, prior to vaccination. The patient has been tested for COVID-19 since having the vaccination. Patient stated that the vertigo continues most mornings but was gone mostly by the time patient finished my shower. There are periods during most days when patient do find himself feeling a bit out of balance. Patient had never experienced vertigo or been diagnosed with vertigo before. Case was reported as non serious. Hospitalization Prolonged was reported as no.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Vertigo
Clinical narrative: extreme vertigo; Could not stand up or sit up for most of that day and Tuesday the 7th of September.; chills; body aches; fever; some fatigue; feeling a bit out of balance; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Sep2021 12:00 (Lot number: FD8448) at the age of 53 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19? Yes. There were no concomitant medications. The following information was reported: CHILLS (non-serious) with onset 01Sep2021 21:00, outcome "not recovered", described as "chills"; PAIN (non-serious) with onset 01Sep2021 21:00, outcome "not recovered", described as "body aches"; PYREXIA (non-serious) with onset 01Sep2021 21:00, outcome "not recovered", described as "fever"; FATIGUE (non-serious) with onset 01Sep2021 21:00, outcome "not recovered", described as "some fatigue"; VERTIGO (non-serious) with onset 06Sep2021, outcome "recovered" (Sep2021), described as "extreme vertigo"; DYSSTASIA (non-serious) with onset 06Sep2021, outcome "not recovered", described as "Could not stand up or sit up for most of that day and Tuesday the 7th of September."; BALANCE DISORDER (non-serious) with onset Sep2021, outcome "not recovered", described as "feeling a bit out of balance". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chills, pain, pyrexia, fatigue, vertigo, dysstasia, balance disorder.  Additional Information: It was reported that the patient had no known allergies. Facility where the most recent COVID-19 vaccine was administered at workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19, prior to vaccination. The patient has been tested for COVID-19 since having the vaccination. Patient stated that the vertigo continues most mornings but was gone mostly by the time patient finished my shower. There are periods during most days when patient do find himself feeling a bit out of balance. Patient had never experienced vertigo or been diagnosed with vertigo before. Case was reported as non serious. Hospitalization Prolonged was reported as no.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Lip swelling, Malaise, Paraesthesia oral
Clinical narrative: lips and cheek were numb and swollen; lips and cheek were numb and swollen; lips and cheek were numb and swollen; left sided swelling of her face; lips tingling and it was like numb; feeling sick; Fever; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 34 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Jan2021 (Lot number: EL3248, Expiration Date: Apr2021) at the age of 34 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: SWELLING FACE (non-serious) with onset 09Jan2021, outcome "recovered" (2021), described as "left sided swelling of her face"; PARAESTHESIA ORAL (non-serious) with onset 09Jan2021, outcome "recovered" (2021), described as "lips tingling and it was like numb"; PYREXIA (non-serious) with onset Jan2021, outcome "unknown", described as "Fever"; HYPOAESTHESIA ORAL (non-serious), LIP SWELLING (non-serious), HYPOAESTHESIA (non-serious) all with onset 09Jan2021, outcome "recovered" (12Jan2021) and all described as "lips and cheek were numb and swollen"; MALAISE (non-serious) with onset 08Jan2021, outcome "unknown", described as "feeling sick".  Additional information: Caller initially says she got her first dose on 06Jan, then says she thinks the date she got it was the 08Jan2021, she can't tell because of how it was written, but she thinks it was the 08Jan2021 She says that the dose was injected in her left arm, because that was the side where she got the reaction to. She says she had left sided swelling of her face, with lips tingling and it was like numb. AE Treatment: Caller says she drank water for treatment. AE Outcome: Caller says it went away on its own. She says she also had a fever, but she felt like that was a normal reaction to the vaccine. No further details provided about her fever. Caller says half of her face was swollen which didn't seem normal, and it looked like Bell's palsy, kind of similar, with tingling and numbing on one side and swelling. She says this started the next day after she got her first dose, so 12-14 hours after getting it, she had got it that morning. Captured as provided by the caller. She says she was feeling sick that night, then the next morning she noticed that her lips and cheek were numb and swollen, and it took about 3 days to go away.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling face
Clinical narrative: lips and cheek were numb and swollen; lips and cheek were numb and swollen; lips and cheek were numb and swollen; left sided swelling of her face; lips tingling and it was like numb; feeling sick; Fever; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 34 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Jan2021 (Lot number: EL3248, Expiration Date: Apr2021) at the age of 34 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: SWELLING FACE (non-serious) with onset 09Jan2021, outcome "recovered" (2021), described as "left sided swelling of her face"; PARAESTHESIA ORAL (non-serious) with onset 09Jan2021, outcome "recovered" (2021), described as "lips tingling and it was like numb"; PYREXIA (non-serious) with onset Jan2021, outcome "unknown", described as "Fever"; HYPOAESTHESIA ORAL (non-serious), LIP SWELLING (non-serious), HYPOAESTHESIA (non-serious) all with onset 09Jan2021, outcome "recovered" (12Jan2021) and all described as "lips and cheek were numb and swollen"; MALAISE (non-serious) with onset 08Jan2021, outcome "unknown", described as "feeling sick".  Additional information: Caller initially says she got her first dose on 06Jan, then says she thinks the date she got it was the 08Jan2021, she can't tell because of how it was written, but she thinks it was the 08Jan2021 She says that the dose was injected in her left arm, because that was the side where she got the reaction to. She says she had left sided swelling of her face, with lips tingling and it was like numb. AE Treatment: Caller says she drank water for treatment. AE Outcome: Caller says it went away on its own. She says she also had a fever, but she felt like that was a normal reaction to the vaccine. No further details provided about her fever. Caller says half of her face was swollen which didn't seem normal, and it looked like Bell's palsy, kind of similar, with tingling and numbing on one side and swelling. She says this started the next day after she got her first dose, so 12-14 hours after getting it, she had got it that morning. Captured as provided by the caller. She says she was feeling sick that night, then the next morning she noticed that her lips and cheek were numb and swollen, and it took about 3 days to go away.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise, Pruritus, Pyrexia, Skin discolouration
Clinical narrative: Just a little itching; He is experiencing a low grade fever; he just feels unwell.; a headache; Some discoloration on his arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRURITUS (non-serious), outcome "unknown", described as "Just a little itching"; PYREXIA (non-serious), outcome "unknown", described as "He is experiencing a low grade fever"; MALAISE (non-serious), outcome "unknown", described as "he just feels unwell."; HEADACHE (non-serious), outcome "unknown", described as "a headache"; SKIN DISCOLOURATION (non-serious), outcome "unknown", described as "Some discoloration on his arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Ear congestion, Fatigue, Hyperhidrosis
Clinical narrative: Swollen face; Sneezing; Blocked ears; Sore throat; Swollen lymph nodes underarms; Fever; Chills; Nausea; Left arm pain; Fatigue; Sweating; Dry tongue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Sep2021 (Lot number: FE 3592) at the age of 31 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "IBS-D" (unspecified if ongoing), notes: IBS-D; "known allergies" (unspecified if ongoing), notes: known allergies: Yes; "IBS-D" (unspecified if ongoing), notes: IBS-D. The patient's concomitant medications were not reported.  The following information was reported: SWELLING FACE (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Swollen face"; SNEEZING (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Sneezing"; EAR CONGESTION (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Blocked ears"; OROPHARYNGEAL PAIN (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Sore throat"; LYMPHADENOPATHY (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Swollen lymph nodes underarms"; PYREXIA (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Fever"; CHILLS (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Chills"; NAUSEA (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Nausea"; PAIN IN EXTREMITY (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Left arm pain"; FATIGUE (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Fatigue"; HYPERHIDROSIS (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Sweating"; TONGUE DRY (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Dry tongue". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of swelling face, sneezing, ear congestion, oropharyngeal pain, lymphadenopathy, pyrexia, chills, nausea, pain in extremity, fatigue, hyperhidrosis, tongue dry.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient not received other medications in two weeks. Post vaccination, the patient was tested for Covid-19.   No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Nausea, Oropharyngeal pain, Pain in extremity, Pyrexia
Clinical narrative: Swollen face; Sneezing; Blocked ears; Sore throat; Swollen lymph nodes underarms; Fever; Chills; Nausea; Left arm pain; Fatigue; Sweating; Dry tongue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Sep2021 (Lot number: FE 3592) at the age of 31 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "IBS-D" (unspecified if ongoing), notes: IBS-D; "known allergies" (unspecified if ongoing), notes: known allergies: Yes; "IBS-D" (unspecified if ongoing), notes: IBS-D. The patient's concomitant medications were not reported.  The following information was reported: SWELLING FACE (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Swollen face"; SNEEZING (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Sneezing"; EAR CONGESTION (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Blocked ears"; OROPHARYNGEAL PAIN (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Sore throat"; LYMPHADENOPATHY (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Swollen lymph nodes underarms"; PYREXIA (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Fever"; CHILLS (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Chills"; NAUSEA (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Nausea"; PAIN IN EXTREMITY (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Left arm pain"; FATIGUE (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Fatigue"; HYPERHIDROSIS (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Sweating"; TONGUE DRY (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Dry tongue". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of swelling face, sneezing, ear congestion, oropharyngeal pain, lymphadenopathy, pyrexia, chills, nausea, pain in extremity, fatigue, hyperhidrosis, tongue dry.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient not received other medications in two weeks. Post vaccination, the patient was tested for Covid-19.   No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Sneezing, Swelling face, Tongue dry
Clinical narrative: Swollen face; Sneezing; Blocked ears; Sore throat; Swollen lymph nodes underarms; Fever; Chills; Nausea; Left arm pain; Fatigue; Sweating; Dry tongue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Sep2021 (Lot number: FE 3592) at the age of 31 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "IBS-D" (unspecified if ongoing), notes: IBS-D; "known allergies" (unspecified if ongoing), notes: known allergies: Yes; "IBS-D" (unspecified if ongoing), notes: IBS-D. The patient's concomitant medications were not reported.  The following information was reported: SWELLING FACE (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Swollen face"; SNEEZING (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Sneezing"; EAR CONGESTION (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Blocked ears"; OROPHARYNGEAL PAIN (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Sore throat"; LYMPHADENOPATHY (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Swollen lymph nodes underarms"; PYREXIA (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Fever"; CHILLS (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Chills"; NAUSEA (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Nausea"; PAIN IN EXTREMITY (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Left arm pain"; FATIGUE (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Fatigue"; HYPERHIDROSIS (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Sweating"; TONGUE DRY (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Dry tongue". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of swelling face, sneezing, ear congestion, oropharyngeal pain, lymphadenopathy, pyrexia, chills, nausea, pain in extremity, fatigue, hyperhidrosis, tongue dry.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient not received other medications in two weeks. Post vaccination, the patient was tested for Covid-19.   No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Blepharospasm, Chest pain
Clinical narrative: Chest pain for 5 days, 4 days after the first dose of Pfizer Covid 19 vaccine.; Left lower eyelid involuntary twitching; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Aug2021 12:45 (Lot number: FD0809) at the age of 44 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Seasonal Bronchitis." (unspecified if ongoing), notes: Other medical history: Seasonal Bronchitis.; "Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin. The patient's concomitant medications were not reported. The following information was reported: BLEPHAROSPASM (non-serious) with onset 29Aug2021, outcome "recovering", described as "Left lower eyelid involuntary twitching"; CHEST PAIN (non-serious) with onset 29Aug2021 12:00, outcome "recovering", described as "Chest pain for 5 days, 4 days after the first dose of Pfizer Covid 19 vaccine.". Therapeutic measures were not taken as a result of blepharospasm, chest pain.  Additional information: The patient received bnt162b2 (BNT162B2), administered in arm left, on unspecified date (Lot number: FF2587) as dose 2, single for covid-19 immunisation. The patient had Chest pain for 5 days, 4 days after the first dose of Pfizer Covid 19 vaccine and left lower eyelid involuntary twitching,4 days after first dose of Pfizer COVID-19 vaccine, which up to the second dose persisted. The patient did not receive any other vaccine within 4 weeks. The patient did not have any other medications the patient received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.   Follow-up attempts are completed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Epistaxis, SARS-CoV-2 test, Tinnitus, Vertigo
Clinical narrative: Nose bleeds with the second shot; Tinnitus; Vertigo; light headed with both shots; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 16Sep2021 16:30 (Lot number: 301458A) at the age of 53 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Psoriasis" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: If COVID prior vaccination: Yes. Concomitant medication(s) included: HUMIRA. Past drug history included: Humira, reaction(s): "known allergies: Humira". Vaccination history included: Bnt162b2 (COVID vaccine details: , Product: COVID 19, Brand: Pfizer , Lot number: FC3184, Lot unknown: False, Administration date: 23Aug2021, Administration time: 04:00 PM, Dose number: 1, Vaccine location: Left arm), administration date: 23Aug2021, when the patient was 53 years old, for Covid-19 immunization, reaction(s): "Tinnitus, Vertigo, light headed with both shots", "Tinnitus, Vertigo, light headed with both shots", "Tinnitus, Vertigo, light headed with both shots". The following information was reported: EPISTAXIS (non-serious) with onset Sep2021, outcome "unknown", described as "Nose bleeds with the second shot"; TINNITUS (non-serious) with onset Sep2021, outcome "unknown", described as "Tinnitus"; VERTIGO (non-serious) with onset Sep2021, outcome "unknown", described as "Vertigo"; DIZZINESS (non-serious) with onset Sep2021, outcome "unknown", described as "light headed with both shots". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: No other vaccine in four weeks. Patient had COVID prior vaccination. COVID tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Chills, Cough, Headache, Myalgia
Clinical narrative: headache; chills; fever; cough; muscular pain; skeletal pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 70 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; CHILLS (non-serious), outcome "unknown", described as "chills"; PYREXIA (non-serious), outcome "unknown", described as "fever"; COUGH (non-serious), outcome "unknown", described as "cough"; MYALGIA (non-serious), outcome "unknown", described as "muscular pain"; BONE PAIN (non-serious), outcome "unknown", described as "skeletal pain".  Additional information: The patient  receive the coverage shot in the morning at eight a m. by six p. m. and the evening he started to feel during the night and  developed chills fever a cough headache and skeletal pain i guess maybe muscular pain as well it's hard to differentiate the two.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: headache; chills; fever; cough; muscular pain; skeletal pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 70 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; CHILLS (non-serious), outcome "unknown", described as "chills"; PYREXIA (non-serious), outcome "unknown", described as "fever"; COUGH (non-serious), outcome "unknown", described as "cough"; MYALGIA (non-serious), outcome "unknown", described as "muscular pain"; BONE PAIN (non-serious), outcome "unknown", described as "skeletal pain".  Additional information: The patient  receive the coverage shot in the morning at eight a m. by six p. m. and the evening he started to feel during the night and  developed chills fever a cough headache and skeletal pain i guess maybe muscular pain as well it's hard to differentiate the two.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arterial occlusive disease, Arthralgia, Blood test, Myalgia, Vaccination site pain
Clinical narrative: muscle and joint pain all over; muscle and joint pain all over; left arm sore at injection site; Clogged arteries; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 60 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31May2021 (Lot number: EW0186) at the age of 60 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Cholesterol" (unspecified if ongoing); "heart" (unspecified if ongoing). Concomitant medication(s) included: LOTRIL [ENALAPRIL MALEATE] taken for blood cholesterol (ongoing); PLAVIX taken for cardiac disorder, start date: Sep2021 (ongoing); LOPROLOL taken for cardiac disorder, start date: Sep2021; ASPIRIN taken for cardiac disorder, start date: Sep2021 (ongoing); LIPITOR (ongoing). Vaccination history included: Bnt162b2 (Dose 1,, Anatomical location: left upper arm,, Batch/lot number: EW0176), administration date: 10May2021, when the patient was 60 years old, for COVID-19 Immunization. The following information was reported: MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset Jul2021, outcome "not recovered" and all described as "muscle and joint pain all over"; VACCINATION SITE PAIN (non-serious) with onset Jul2021, outcome "not recovered", described as "left arm sore at injection site"; ARTERIAL OCCLUSIVE DISEASE (non-serious) with onset Jul2021, outcome "recovered" (2021), described as "Clogged arteries". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: About a month and a half after he began experiencing severe muscle and joint pain all over his body. His left upper arm where he received the injection was very sore and it continues. His doctor found him to have clogged arteries and that was fixed. Before this patient was active and played golf. He was having muscle pain all over the place, states it was from his left knee then goes to left elbow, then to right elbow, to right knee, it changes. Reporter does not clarify treatment for muscle pain. Patient also has clogged arteries, diagnosed three weeks ago, states he had them fixed. States the doctors started him on other medication and now he does not know if it is the new medication causing this. States he was also sore in the left arm where he got injection. Caller states he was taking Lipitor, does not know if he was taking that for cholesterol or blood pressure, states he been taking this for years, 25-30 years, no further details provided. States he just started going to the doctor for this, states pain was unbelievable, in so much pain in his joints, no one seems to know, blood work has been fine. Patient has been taking Lotril for years. Patient just started Plavix, Loprolol, Aspirin two weeks ago. There was no patient history and investigation assessment.  No follow-up attempts are possible. No further information is expected.